Vifor Pharma

Vifor Pharma Group (formerly Galenica Group) is a pharmaceutical company focused on nephrology, dedicated to researching, developing, manufacturing, and marketing its own pharmaceutical products. It is the preferred partner for innovative solutions tailored to patients. The company aims to become a global leader in iron deficiency, nephrology, and cardio-renal therapies, striving to help patients worldwide suffering from severe and chronic diseases lead better and healthier lives. Vifor Pharma Group has production facilities in Switzerland and Portugal, as well as a dynamic network of branches and partners spanning global markets.The company’s operations are continuously expanding worldwide while maintaining strong roots in its home market of Switzerland. It is listed on the SIX Swiss Exchange (VIFN, ISIN: CH0364749348).